When assessing cardiovascular disease risk, it may be more appropriate to be guided by the LDL-C level or, preferably, the non-HDL-C level, than the total cholesterol level.
Plasma lipid and lipoprotein levels affect an individual's risk of serious cardiovascular disease (CVD) events and acute pancreatitis. Endocrinologists, primary care physicians and health professionals who specialise in diabetes now require a greater level of sophistication in their understanding of lipid and lipoprotein tests. Guidelines concerning utilisation and interpretation of these tests continue to evolve.
Picture credit: © Gary Carlson/Science Source/Diomedia.com